An Open-Label, Randomized, Two-Period Crossover Study of the NuvaRing Applicator in Healthy Women

被引：0
|
作者：
Feldman, Robert [1 ]
Frenkl, Tara [1 ]
Yacik, Carol [1 ]
Wang, Yinna [1 ]
Fox, Michelle [1 ]
机构：
[1] Miami Res Associates, Miami, FL USA
来源：
OBSTETRICS AND GYNECOLOGY | 2016年 / 127卷
关键词：
D O I：
10.1097/01.AOG.0000483477.23575.e2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
8N
引用
收藏
页码：116S / 116S
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study
    Feldman, Robert
    Frenkl, Tara L.
    Yacik, Carol
    Wang, Yinna
    Fox, Michelle C.
    [J]. CONTRACEPTION, 2016, 94 (04) : 362 - 365
  • [2] A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults
    Park, Kyungsoo
    Kim, Yu Seun
    Kwon, Kwang-il
    Park, Min Soo
    Lee, Yoon Jung
    Kim, Kyung Hwan
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (01) : 154 - 162
  • [3] A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers
    Jiang, Xin
    Tao, Ye
    Liu, Yanping
    Shi, Ping
    Li, Ting
    Sun, Feifei
    Cao, Yu
    Wang, Chenjing
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1087 - 1093
  • [4] Bioequivalence Evaluation of Single Doses of Two Tramadol Formulations: A Randomized, Open-Label, Two-Period Crossover Study in Healthy Brazilian Volunteers
    Silva, Marina de Freitas
    Schramm, Simone Grigoleto
    Kano, Eunice Kazue
    Mori Koono, Eunice Emiko
    Porta, Valentina
    dos Reis Serra, Cristina Helena
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (04) : 758 - 765
  • [5] An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations
    Levinson, RS
    Mitan, SJ
    Steinmetz, JI
    Gattermeir, DJ
    Schumacher, RJ
    Joffrion, JL
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (12) : 1894 - 1900
  • [6] Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: A randomized, open-label, two-period, comparative crossover study
    Park, JY
    Kim, KA
    Park, PW
    Suh, KH
    Lee, GS
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (12) : 2092 - 2101
  • [7] Bioavailability of two oral formulations of azithromycin 500 mg:: A randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects
    Piñeyro-López, A
    Piñeyro-Garza, E
    Torres-Alanís, O
    Reyes-Araiza, R
    Silva, MG
    Wacksman, N
    Rangel, RL
    de Lago, A
    González-de la Parra, M
    Namur, S
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (10) : 1607 - 1611
  • [8] Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects
    Park, JY
    Kim, KA
    Lee, GS
    Park, PW
    Kim, SL
    Lee, YS
    Lee, YW
    Shin, EK
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (05) : 715 - 723
  • [9] Pharmacokinetics, bioequivalence, and safety studies of gefitinib tablet formulations: A randomized, open-label, two-period, two-sequence crossover study in Chinese healthy volunteers
    Du, Ping
    Zhao, Zhixia
    Yu, Weiyue
    Zhao, Rui
    Liu, Hongchuan
    Li, Pengfei
    Liu, Lihong
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84
  • [10] Pharmacokinetic study of two extended-release formulations of cilostazol in healthy Korean subjects: A randomized, open-label, multiple-dose, two-period crossover study
    Shin, Wonsuk
    Kim, Min-Kyoung
    Cho, Doo-Yeoun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (08) : 408 - 415
12345